FDA Approves AI Medical App for Vital Signs
The General Authority for Food and Drug Administration in the Kingdom has granted a permit to market a medical digital application that utilizes artificial intelligence technologies to measure vital signs such as heart rate, oxygen saturation, and blood pressure through the camera of smart devices. This approval came after comprehensive evaluations ensuring safety and effectiveness. The application relies on remote optical imaging technology and advanced algorithms, and it requires blood pressure calibration using an approved medical device. This decision reflects the Kingdom's direction toward supporting innovation in digital health as part of its Vision 2030, and it is considered the first of its kind worldwide.
Notice: This Is an AI-Generated Summary
Comments (0)